Zinzani P - Search Results

1

Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.

Mikulska M, Testi D, Russo C, Balletto E, Sepulcri C, Bussini L, Dentone C, Magne F, Policarpo S, Campoli C, Miselli F, Cilli A, Ghiggi C, Aquino S, Di Grazia C, Giannella M, Giacobbe DR, Vena A, Raiola AM, Bonifazi F, Zinzani P, Cavo M, Lemoli R, Angelucci E, Viale P, Bassetti M, Bartoletti M. Mikulska M, et al. Among authors: zinzani p. Br J Haematol. 2023 May;201(4):628-639. doi: 10.1111/bjh.18690. Epub 2023 Feb 20. Br J Haematol. 2023. PMID: 36806152

2

Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.

Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Cavo M, Galieni P, Tassi C, et al. Tura S, et al. Among authors: zinzani pl. Cancer Chemother Pharmacol. 1989;23(2):123-5. doi: 10.1007/BF00273532. Cancer Chemother Pharmacol. 1989. PMID: 2910510

3

FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report.

Visani G, Tosi P, Zinzani PL, Manfroi S, Zaccaria A, Testoni N, Lemoli RM, Rosti G, Pelliconi S, Tura S. Visani G, et al. Among authors: zinzani pl. Br J Haematol. 1994 Feb;86(2):394-6. doi: 10.1111/j.1365-2141.1994.tb04749.x. Br J Haematol. 1994. PMID: 7515268

4

Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia.

Zinzani PL, Lauria F, Rondelli D, Benfenati D, Raspadori D, Bocchia M, Gozzetti A, Cavo M, Cirio TM, Zaja F, et al. Zinzani PL, et al. Eur J Haematol. 1993 Aug;51(2):93-7. doi: 10.1111/j.1600-0609.1993.tb01599.x. Eur J Haematol. 1993. PMID: 8370424

5

Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.

Lemoli RM, Rosti G, Visani G, Gherlinzoni F, Miggiano MC, Fortuna A, Zinzani P, Tura S. Lemoli RM, et al. Among authors: zinzani p. J Clin Oncol. 1996 Nov;14(11):3018-25. doi: 10.1200/JCO.1996.14.11.3018. J Clin Oncol. 1996. PMID: 8918500 Clinical Trial.

6

Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.

Zinzani PL, Bendandi M, Magagnoli M, Rondelli D, de Vivo A, Benni M, Zamagni E, Cavo M, Tura S. Zinzani PL, et al. Eur J Haematol. 1997 Aug;59(2):82-8. doi: 10.1111/j.1600-0609.1997.tb00730.x. Eur J Haematol. 1997. PMID: 9293855 Clinical Trial.

7

Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.

Zinzani PL, Tani M, Molinari AL, Stefoni V, Zuffa E, Alinari L, Gabriele A, Bonifazi F, Salvucci M, Tura S, Baccarani M. Zinzani PL, et al. Haematologica. 2002 Aug;87(8):816-21. Haematologica. 2002. PMID: 12161357

8

Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.

Isidori A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, Rizzi S, Giudice V, Farese O, Rovito M, Alinari L, Conte R, Baccarani M, Lemoli RM. Isidori A, et al. Among authors: zinzani p. Haematologica. 2005 Feb;90(2):225-31. Haematologica. 2005. PMID: 15710576 Clinical Trial.

9

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.

Ibatici A, Pica GM, Nati S, Vitolo U, Botto B, Ciochetto C, Petrini M, Galimberti S, Ciabatti E, Orciuolo E, Zinzani PL, Cascavilla N, Guolo F, Fraternali Orcioni G, Carella AM. Ibatici A, et al. Br J Haematol. 2014 Mar;164(5):710-6. doi: 10.1111/bjh.12695. Epub 2013 Dec 17. Br J Haematol. 2014. PMID: 24344981 Free article. Clinical Trial.

10

Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience.

Stefoni V, Broccoli A, Argnani L, Sabattini E, Cavo M, Zinzani PL. Stefoni V, et al. Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):297-299. doi: 10.1016/j.clml.2018.02.007. Epub 2018 Feb 16. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29500149 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page